Trademark Attorney / Law Firm

CHARLES NAVE – Trademark Portfolio

CHARLES NAVE specializes in Class 36 (Insurance & Financial) trademark filings before the United States Patent and Trademark Office (USPTO), with 3 of 4 total filings concentrated in this category. The practice also covers Class 35 (Advertising & Business) along with 3 other Nice Classification classes. Filing activity spans from 2018 to 2019. Currently, 0 trademarks are registered.

4 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

CHARLES NAVE's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

36
Insurance & Financial (3 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademark applications has CHARLES NAVE filed?

CHARLES NAVE has filed 4 trademark applications with the United States Patent and Trademark Office (USPTO).

What trademark classes does CHARLES NAVE specialize in?

CHARLES NAVE has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 36 (Insurance & Financial), Class 35 (Advertising & Business), Class 30 (Staple Foods). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

How long has CHARLES NAVE been filing trademarks?

CHARLES NAVE's trademark filing history with the USPTO spans from 2018 to 2019, covering 1 year of trademark practice. During this period, CHARLES NAVE has handled 4 trademark applications.

What is CHARLES NAVE's trademark registration success rate?

CHARLES NAVE has a 0% trademark registration rate, with 0 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.